ANIDO ARMANDO (Chairman & Chief Exec. Officer) received a stock award from ZYNERBA PHARMACEUTICALS, INC.
Compensation award — not an open‑market transaction. Less informative as a directional signal.
A · 1 award
Filed: 2/9/2023ACC: 0000899243-23-004442
DirectorOfficer· Chairman & Chief Exec. Officer
Since Aug 2018
+32.86K
Net shares
Net buyer
$7.5K
Total sold
0
Open market trades
0B · 0S
2
Total transactions
45.41K acquired · 12.55K disposed
Non-Derivative Transactions2
Common Stock
Direct
Shares
+45.41K
Price / share
—
Trade value
—
% of position
5.3%
2/7/2023
856.95K→902.35K
Common Stock
Direct
Shares
−12.55K
Price / share
$0.60
Trade value
$7.48K
% of position
1.4%
2/8/2023
902.35K→889.80K
Total
Net shares
+32.86K
Net value
-$7.48K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 2/7/2023 | A · Award | +45.41K | — | — | 5.3% | 856.95K | 902.35K |
| Common Stock Direct | 2/8/2023 | F · Tax Withholding | −12.55K | $0.60 | $7.48K | 1.4% | 902.35K | 889.80K |
| Total | +32.86K | -$7.48K | ||||||
Derivative Transactions0
No derivative transactions reported
Non-Derivative Holdings (Post-Transaction)2
Common Stock
IndirectShares owned26.59K
Common Stock
IndirectShares owned13.30K
Total
39.89K indirect39.89K
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 26.59K | Indirect |
| Common Stock | 13.30K | Indirect |
| Total | 39.89K | 39.89K indirect |
Derivative Holdings (Post-Transaction)0
No derivative holdings reported